Jonathan M. Davis, MD

Tufts CTSI Associate Director and Director of the Trial Innovation Liaison Team
Tufts CTSI; Tufts Medical Center

Dr. Davis is Vice-Chair of Pediatrics and Chief of Newborn Medicine at Tufts Medical Center and Professor of Pediatrics at Tufts University School of Medicine. His research has focused on neonatal drug development, including optimizing approaches to treat neonatal abstinence syndrome.  He is currently funded by NIH and FDA to develop better biomarkers and outcome measures for clinical trials and new and existing therapeutics to improve neonatal outcome. Dr. Davis is Chair of the Neonatal Advisory Committee in the Office of the Commissioner at FDA and Associate Director of the Tufts CTSI.  He is Co-PI of a recent $8M NIH award to Tufts Medical Center to fund a national clinical trial studying the integration of targeted genomic sequencing into neonatal diagnosis and care.